P = 0.003), and a greater proportion of patients developed osteoporosis than in the zoledronic acid group. We could postulate that patients who had premature menopause without regain of ovarian ...

intravenous zoledronic acid or intravenous ibandronic acid are alternative options for the treatment of osteoporosis in patients with celiac disease.

A single IV dose of the bisphosphonate drug zoledronic acid has been shown to increase bone density at 1 year in women with osteopenia or osteoporosis (Journal Watch Mar 8 2002 and N Engl J Med ...

bisphosphonate zoledronic acid) for the prevention of osteoporosis associated with breast cancer treatment in premenopausal women. The safety profile in these women appears to be comparable with ...

Zoledronic acid is used to treat high levels of a mineral called calcium in people who have cancer. It is also used to treat or prevent weakening of the bones (osteoporosis) caused by menopause or ...

Osteoporosis generally strikes older adults ... denosumab (Prolia), teriparatide (Forteo), and zoledronic acid (Reclast) are injectables, and Premarin is available as a tablet, an injectable ...

If you've been given a diagnosis of osteoporosis your doctor will probably ... There is also the once-a-year injection drug, zoledronic acid (Reclast, Zometa). But research has found that ...

Osteoporosis: the ‘silent' condition Roughly ... They include biphosphonates such as alendronate (Fosamax), a weekly pill, ...

I am also the lead investigator in studies evaluating current osteoporosis treatments further, like denosumab and zoledronic acid. I have supported and continue to support a number of clinical trials ...

Discover top medications for 'treating Osteoporosis'? This page compiles essential information on generic and brand-name drugs specifically used for Osteoporosis treatment.Here, you can explore ...

July 24, 2024 — Surgeons compared traditional and new fully hydroxyapatite-coated hip replacement stems. They found the new stems offer larger contact areas, while traditional ones preserve bone ...

I became an NIHR Senior Investigator in 2009. Some of my recent contributions have been authorship on key papers describing new treatments for osteoporosis, such as tibolone, zoledronic acid, ...